Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MKNK1 | Q9BUB5 | 11/20 | 0.47 |
| ▸ | MKNK2 | Q9HBH9 | 11/20 | 0.47 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | FDFT1 | P37268 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.35 |
| ▸ | FYN | P06241 | 1/20 | 0.34 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.34 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.34 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6135099 | 0.90 | MKNK1 (0.45) | MKNK1MKNK2DGAT1 | |
| Hydrochloric Acid SCHEMBL6135066 | 0.89 | MKNK1 (0.44) | MKNK1MKNK2DGAT1 | |
| SCHEMBL6134866 | 0.84 | MAPT (0.44) | DGAT1MAPT | |
| SCHEMBL6134798 | 0.84 | MKNK1 (0.41) | MKNK1MKNK2SIRT2 | |
| SCHEMBL6135144 | 0.83 | MKNK1 (0.47) | MKNK1MKNK2FDFT1KCNH2HRH3 | |
| SCHEMBL6135241 | 0.83 | MKNK1 (0.40) | MKNK1MKNK2SIRT2 | |
| SCHEMBL6134597 | 0.83 | MKNK1 (0.48) | MKNK1MKNK2MAPTFDFT1HRH3 | |
| SCHEMBL6132310 | 0.83 | HTT (0.44) | MAPTFDFT1 | |
| SCHEMBL6132537 | 0.82 | MKNK1 (0.52) | MKNK1MKNK2MAPTKCNH2HRH3 | |
| SCHEMBL6132749 | 0.82 | HTT (0.43) | MAPTFDFT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050261177-A1 | Compound | ASTELLAS PHARMA INC. (JP) | 2005-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050261177-A1 | Compound | MANBA, MAN2B1, MAN2A1 | MKNK1 2695/4885MKNK2 3220/4885DGAT1 3670/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.